AR028823A1 - 8a y 9a lactamas de 15 miembros de la clase 6-o-metil-eritromicina a, un procedimiento para su preparacion y una composicion farmaceutica util para el tratamiento de infecciones bacterianas en seres humanos y animales - Google Patents
8a y 9a lactamas de 15 miembros de la clase 6-o-metil-eritromicina a, un procedimiento para su preparacion y una composicion farmaceutica util para el tratamiento de infecciones bacterianas en seres humanos y animalesInfo
- Publication number
- AR028823A1 AR028823A1 ARP000101906A ARP000101906A AR028823A1 AR 028823 A1 AR028823 A1 AR 028823A1 AR P000101906 A ARP000101906 A AR P000101906A AR P000101906 A ARP000101906 A AR P000101906A AR 028823 A1 AR028823 A1 AR 028823A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- members
- ketone
- erythromycin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
Abstract
Se refiere a nuevas 8S- y 9S-lactamas de 15 miembros de la clase de 6-O-metil-eritromicina A de formula general (1) sus sales de adicion farmacéuticamente aceptables con ácidos inorgánicos u orgánicos y sus hidratos, donde A representa un grupo NH y B representa simultáneamente un grupo C = O, o A representa un grupo C = O y B representa simultáneamente un grupo NH. R1 representa un grupo OH, un grupo L û cladinosilo de formula (2) o R1 representa un grupo de formula (3) donde Y representa hidrogeno, alquilo C1-6, un grupo alquilo C1-6 con al menos un átomo incorporado de O, N o S, o Y representa (CH2)n û Ar, donde (CH2)n representa alquilo y n representa 1-10, con o sin átomos O, N o S incorporados, y Ar representa un anillo aromático monocíclico o bicíclico de 5 û 10 miembros que contiene 0 - 3 átomos de O, N o S, sustituido o insustituido con 1 û 3 grupos que representan halogeno, OH, OMe, NO2, NH2, amino alquilo C1-3 o amino dialquilo C1-3, CN, SO2NH2, alquilo C1-3, o R1 junto con R2 representa cetona, R2 representa hidrogeno o junto con R1 representa cetona, R3 representa hidrogeno o un grupo alcanoilo C1-4, R4 representa hidrogeno o junto con R5 representa cetona, R5 representa OH, NH2, amino alquilo C1-3 o amino dialquilo C1-3, O(CH2)nAr o S (CH2)nûAr, donde (CH2)n y Ar tienen los significados dados previamente, o junto con R4 representan cetona, R6 representan hidrogeno, alquilo C1-6, un grupo alquilo C1-6 con al menos un átomo O, N o S incorporado, o un grupo (CH2)nûAr, donde (CH2)n y Ar tienen los significados dados previamente, o R5 y R6, junto con los átomos intervinientes, forman un anillo adicional de formula (4a) y (4b).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR990116A HRP990116B1 (en) | 1999-04-20 | 1999-04-20 | NOVEL 8a AND 9a- 15-MEMBERED LACTAMES |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028823A1 true AR028823A1 (es) | 2003-05-28 |
Family
ID=10946907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101906A AR028823A1 (es) | 1999-04-20 | 2000-04-24 | 8a y 9a lactamas de 15 miembros de la clase 6-o-metil-eritromicina a, un procedimiento para su preparacion y una composicion farmaceutica util para el tratamiento de infecciones bacterianas en seres humanos y animales |
Country Status (33)
Country | Link |
---|---|
US (1) | US6593360B1 (es) |
EP (1) | EP1181298B1 (es) |
JP (1) | JP2002542254A (es) |
KR (1) | KR20020007379A (es) |
CN (1) | CN1246327C (es) |
AR (1) | AR028823A1 (es) |
AT (1) | ATE333461T1 (es) |
AU (1) | AU772272B2 (es) |
BG (1) | BG65281B1 (es) |
BR (1) | BR0009943A (es) |
CA (1) | CA2370273A1 (es) |
CZ (1) | CZ20013730A3 (es) |
DE (1) | DE60029439T2 (es) |
DK (1) | DK1181298T3 (es) |
EA (1) | EA003928B1 (es) |
EE (1) | EE04553B1 (es) |
ES (1) | ES2267519T3 (es) |
GE (1) | GEP20032929B (es) |
HK (1) | HK1049842B (es) |
HR (1) | HRP990116B1 (es) |
HU (1) | HUP0200868A3 (es) |
IL (1) | IL145990A0 (es) |
IS (1) | IS6110A (es) |
MX (1) | MXPA01010627A (es) |
NO (1) | NO320704B1 (es) |
NZ (1) | NZ515279A (es) |
PL (1) | PL351523A1 (es) |
PT (1) | PT1181298E (es) |
SK (1) | SK14942001A3 (es) |
TR (1) | TR200103019T2 (es) |
UA (1) | UA72246C2 (es) |
WO (1) | WO2000063223A1 (es) |
ZA (1) | ZA200108481B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0025688D0 (en) | 2000-10-19 | 2000-12-06 | Glaxo Group Ltd | Macrolides |
HRP20020779A2 (en) | 2002-09-27 | 2005-02-28 | Pliva-Istra�iva�ki institut d.o.o. | NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES |
US7435805B2 (en) * | 2003-05-30 | 2008-10-14 | Glaxpsmithkline Istrazivacki | O-alkyl macrolide and azalide derivatives and regioselective process for their preparation |
EP1879903A1 (en) | 2005-05-10 | 2008-01-23 | GlaxoSmithKline istrazivacki centar Zagreb d.o.o. | Ether linked macrolides useful for the treatment of microbial infections |
EP2988597B1 (en) | 2013-04-04 | 2022-06-08 | President and Fellows of Harvard College | Macrolides and methods of their preparation and use |
JP2017531663A (ja) | 2014-10-08 | 2017-10-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 14員ケトライドならびにそれらの調製および使用の方法 |
WO2016154591A1 (en) | 2015-03-25 | 2016-09-29 | President And Fellows Of Harvard College | Macrolides with modified desosamine sugars and uses thereof |
GB201608236D0 (en) | 2016-05-11 | 2016-06-22 | Fidelta D O O | Seco macrolide compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI7910768A8 (en) * | 1979-04-02 | 1996-06-30 | Pliva Pharm & Chem Works | Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives |
SI9011409A (en) * | 1990-07-18 | 1995-10-31 | Pliva Pharm & Chem Works | O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them |
IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
WO1997042204A1 (en) * | 1996-05-07 | 1997-11-13 | Abbott Laboratories | 6-o-substituted erythromycins and method for making them |
AU1082599A (en) * | 1997-10-16 | 1999-05-03 | Merck & Co., Inc. | 8a-azalides, compositions containing such compounds and methods of treatment |
HRP980189B1 (en) * | 1998-04-06 | 2004-04-30 | Pliva Pharm & Chem Works | Novel 15-membered lactams ketolides |
-
1999
- 1999-04-20 HR HR990116A patent/HRP990116B1/xx not_active IP Right Cessation
-
2000
- 2000-04-19 UA UA2001117855A patent/UA72246C2/uk unknown
- 2000-04-19 TR TR2001/03019T patent/TR200103019T2/xx unknown
- 2000-04-19 BR BR0009943-0A patent/BR0009943A/pt not_active IP Right Cessation
- 2000-04-19 DK DK00920937T patent/DK1181298T3/da active
- 2000-04-19 CZ CZ20013730A patent/CZ20013730A3/cs unknown
- 2000-04-19 HU HU0200868A patent/HUP0200868A3/hu unknown
- 2000-04-19 EP EP00920937A patent/EP1181298B1/en not_active Expired - Lifetime
- 2000-04-19 PL PL00351523A patent/PL351523A1/xx unknown
- 2000-04-19 CN CNB008078238A patent/CN1246327C/zh not_active Expired - Fee Related
- 2000-04-19 AT AT00920937T patent/ATE333461T1/de not_active IP Right Cessation
- 2000-04-19 NZ NZ515279A patent/NZ515279A/xx unknown
- 2000-04-19 CA CA002370273A patent/CA2370273A1/en not_active Abandoned
- 2000-04-19 WO PCT/HR2000/000009 patent/WO2000063223A1/en active IP Right Grant
- 2000-04-19 GE GEAP20006202A patent/GEP20032929B/en unknown
- 2000-04-19 JP JP2000612313A patent/JP2002542254A/ja active Pending
- 2000-04-19 ES ES00920937T patent/ES2267519T3/es not_active Expired - Lifetime
- 2000-04-19 AU AU41347/00A patent/AU772272B2/en not_active Ceased
- 2000-04-19 SK SK1494-2001A patent/SK14942001A3/sk unknown
- 2000-04-19 DE DE60029439T patent/DE60029439T2/de not_active Expired - Fee Related
- 2000-04-19 PT PT00920937T patent/PT1181298E/pt unknown
- 2000-04-19 IL IL14599000A patent/IL145990A0/xx unknown
- 2000-04-19 EE EEP200100544A patent/EE04553B1/xx not_active IP Right Cessation
- 2000-04-19 MX MXPA01010627A patent/MXPA01010627A/es active IP Right Grant
- 2000-04-19 US US09/959,204 patent/US6593360B1/en not_active Expired - Fee Related
- 2000-04-19 KR KR1020017013433A patent/KR20020007379A/ko not_active Application Discontinuation
- 2000-04-19 EA EA200101103A patent/EA003928B1/ru not_active IP Right Cessation
- 2000-04-24 AR ARP000101906A patent/AR028823A1/es unknown
-
2001
- 2001-10-16 ZA ZA200108481A patent/ZA200108481B/xx unknown
- 2001-10-16 IS IS6110A patent/IS6110A/is unknown
- 2001-10-18 NO NO20015068A patent/NO320704B1/no unknown
- 2001-11-20 BG BG106117A patent/BG65281B1/bg unknown
-
2003
- 2003-01-23 HK HK03100592.9A patent/HK1049842B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0003731A2 (hu) | 4-Bróm- vagy 4-jód-fenil-amino-benzhidroxámsav-származékok és ilyen vegyületek MEK gátlóként való alkalmazása | |
UY26943A1 (es) | Derivados de piridina | |
CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
CY1107080T1 (el) | Υποκατεστημενες ινδολο-βασεις του mannich | |
TR200002953T2 (tr) | İki halkalı hidroksamik asit türevleri | |
TR200401432T4 (tr) | Admantan türevleri | |
HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
AR029210A1 (es) | DERIVADOS DE N-(5-SULFAMOIL-1,3-TIAZOL-2-IL) ACETAMIDA, PROCEDIMIENTO PARA SU PREPARACIoN, COMPUESTOS INTERMEDIARIOS, COMPOSICIoN FARMACÉUTICA, Y EL USO DE DICHOS DERIVADOS PARA LA PRODUCCIoN DE MEDICAMENTOS | |
HUP0102793A2 (hu) | Agydaganat kezelésére szolgáló kinazolinok és ezeket tartalmazó gyógyszerkészítmények | |
ATE175201T1 (de) | Mono-n-substituierte 1,4,7,10- tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel | |
KR880011142A (ko) | 피페라지닐-헤테로 시클릭 화합물 | |
ES2058527T3 (es) | Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen. | |
CY1108339T1 (el) | Παραγωγα spiro(2h-1-benzopyran-2,4´-piperidine) ως αναστολεις της μεταφορας γλυκινης | |
ATE327977T1 (de) | Tetrahydrochinolin-derivate als crth2 antagonisten | |
EA200200571A1 (ru) | Новая композиция и ее применение | |
CY1107861T1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν τερβιναφινη και η χρηση τους | |
DK1299382T3 (da) | Præparat og antiviral virkning af substituerede indoloxoeddikesyrepiperazinderivater | |
DE3650138D1 (de) | Mittel zur bekämpfung des schmerzes, der depression und zur beruhigung. | |
ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
CY1107312T1 (el) | Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της | |
DK0503349T3 (da) | Hydrazonderivater samt fremstilling og anvendelse deraf | |
AR028823A1 (es) | 8a y 9a lactamas de 15 miembros de la clase 6-o-metil-eritromicina a, un procedimiento para su preparacion y una composicion farmaceutica util para el tratamiento de infecciones bacterianas en seres humanos y animales | |
BRPI0417858A (pt) | composto, composição farmacêutica, e, uso de uma composição farmacêutica | |
HUP0103072A2 (hu) | Növekedési hormon kiválasztást elősegítő vegyületek alkalmazása | |
HUP0302441A2 (hu) | Antibiotikus hatású gyógyászati készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |